Company
United StatesPublic company, NYSE: PFEPfizer Inc. (NYSE: PFE), San Diego, CA – FDA Inspections
Inspection records and compliance data for Pfizer Inc. in San Diego, California. 3 FDA inspections on record, 1 warning letter, last inspected February 13, 2026. Publicly traded as NYSE: PFE.
Company Profile
This profile covers Pfizer Inc. based in San Diego, California, United States.
FDA Inspection History
- FDA inspections
- 3
- OAI
- 0
- VAI
- 0
- NAI
- 2
- Unclassified
- 1
- Form 483s
- 0
- Warning letters
- 1
First inspected May 5, 2023. Last inspected February 13, 2026.
FDA inspections (3)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| February 13, 2026 | Not classified | Biologics | 1304600 |
| August 22, 2025 | NAI | Human Drugs · Bioresearch Monitoring | 1279984 |
| May 5, 2023 | NAI | Human Drugs · Bioresearch Monitoring | 1206805 |
FDA documents
Warning Letters (1)
Other FDA documents (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Pfizer Inc.
Stock ticker
PFE
Exchange
NYSE
Share price
$28.84
Market cap
$164.4B
Price as of
November 13, 2026
FEI Number
3001433984
Address
10770 Science Center Dr, San Diego, California 92121, United States
Country
United States
ID: b79becc3-ec19-4838-ba1d-fff1abe0c54e